A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
Public ClinicalTrials.gov record NCT00545129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER EFFICACY AND SAFETY STUDY OF TANEZUMAB AS ADD-ON THERAPY TO OPIOID MEDICATION IN PATIENTS WITH PAIN DUE TO BONE METASTASES
Study identification
- NCT ID
- NCT00545129
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Interventions
- IV Placebo for tanezumab Drug
- Tanezumab 10 mg IV Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 28, 2009
- Primary completion
- Dec 23, 2011
- Completion
- Feb 6, 2012
- Last update posted
- Jun 17, 2021
2009 – 2012
United States locations
- U.S. sites
- 12
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD Center for Pain Medicine | La Jolla | California | 92037-7651 | — |
| UCSD Medical Center - Thornton Hospital | La Jolla | California | 92037-7651 | — |
| UCSD Moores Cancer Center | La Jolla | California | 92093 | — |
| Indiana Pain and Spine Clinic | South Bend | Indiana | 46617 | — |
| WK River Cities Clinical Research Center | Shreveport | Louisiana | 71105 | — |
| Willis Knighton Pierremont Health Center | Shreveport | Louisiana | 71115 | — |
| Hollings Cancer Center | Charleston | South Carolina | 29425 | — |
| Medical University of South Carolina, Department of Urology | Charleston | South Carolina | 29425 | — |
| MUSC Department of Radiology | Charleston | South Carolina | 29425 | — |
| MUSC Investigational Pharmacy | Charleston | South Carolina | 29425 | — |
| MUSC Urology Ambulatory Care | Charleston | South Carolina | 29425 | — |
| Huntsman Cancer Institute at the University of Utah | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00545129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2021 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00545129 live on ClinicalTrials.gov.